Dexmedetomidine on Postoperative Cognitive Dysfunction and Serum Tau-217 Protein.

Clinical trial NCT06366412 · UNKNOWN

Trial details

NCT number: NCT06366412
Sponsor: Minia University Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Cognitive Impairment

Start date: 2024-04-01
Primary completion: 2025-03-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.